This paper is only available as a PDF. To read, Please Download here.
Abstract
The regulation of foods and drugs in the United States has repeatedly been increased
in response to unjustified marketing claims or instances of dramatic harm from these
substances. Because drugs are never safe or effective for everyone, the guiding principle
for physicians should be to use pharmaceuticals in such a way as to maximize benefit
and minimize harm.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical TherapeuticsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Study cites adverse medication reactions in many patient deaths.The Boston Globe. 1998; (15): A8
- Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies.JAMA. 1998; 279: 1200-1205
- The Jungle. Heritage Press, New York1965
- Toward the operational identification of adverse drug reactions.Clin Pharmacol Ther. 1977; 21: 247-254
- Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: A regulatory perspective.Clin Pharmacol Ther. 1995; 58: 108-117
- Epidemics. W. Heinemann, London1923 (Book I, Sect. 12. Translation by Jones WHS)
- User's guides to the medical literature—XIV. How to decide on the applicability of clinical trial results to your patient.JAMA. 1998; 279: 545-549
Article info
Identification
Copyright
© 1998 Published by Elsevier Inc.
